These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12876706)

  • 1. Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver.
    Klomp DW; Van Laarhoven HW; Kentgens AP; Heerschap A
    Magn Reson Med; 2003 Aug; 50(2):303-8. PubMed ID: 12876706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.
    van Laarhoven HW; Klomp DW; Kamm YJ; Punt CJ; Heerschap A
    Cancer Res; 2003 Nov; 63(22):7609-12. PubMed ID: 14633676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy.
    Semmler W; Bachert-Baumann P; Gückel F; Ermark F; Schlag P; Lorenz WJ; van Kaick G
    Radiology; 1990 Jan; 174(1):141-5. PubMed ID: 2104675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver.
    Klomp D; van Laarhoven H; Scheenen T; Kamm Y; Heerschap A
    NMR Biomed; 2007 Aug; 20(5):485-92. PubMed ID: 17131325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective 19F MR imaging of 5-fluorouracil and alpha-fluoro-beta-alanine.
    Brix G; Bellemann ME; Zabel HJ; Bachert P; Lorenz WJ
    Magn Reson Imaging; 1993; 11(8):1193-201. PubMed ID: 8271906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra- and extracellular fluorouracil uptake: assessment with contrast-enhanced metabolic F-19 MR imaging.
    Brix G; Bellemann ME; Gerlach L; Haberkorn U
    Radiology; 1998 Oct; 209(1):259-67. PubMed ID: 9769841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallbladder localization of (19)F MRS catabolite signals in patients receiving bolus and protracted venous infusional 5-fluorouracil.
    Dzik-Jurasz AS; Collins DJ; Leach MO; Rowland IJ
    Magn Reson Med; 2000 Oct; 44(4):516-20. PubMed ID: 11025505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?
    McIntyre DJ; Howe FA; Ladroue C; Lofts F; Stubbs M; Griffiths JR
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):29-36. PubMed ID: 20821329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 19F-[1H] nuclear Overhauser effect and proton decoupling of 5-fluorouracil and alpha-fluoro-beta-alanine.
    Krems B; Bachert P; Zabel HJ; Lorenz WJ
    J Magn Reson B; 1995 Aug; 108(2):155-64. PubMed ID: 7648013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
    Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR
    Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.
    Presant CA; Wolf W; Albright MJ; Servis KL; Ring R; Atkinson D; Ong RL; Wiseman C; King M; Blayney D
    J Clin Oncol; 1990 Nov; 8(11):1868-73. PubMed ID: 2230874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
    Harada M; Nishitani H; Shirahama T; Koga K; Miura I
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy for measuring the biodistribution and in situ in vivo pharmacokinetics of fluorinated compounds: validation using an investigation of liver and heart disposition of tecastemizole.
    Schneider E; Bolo NR; Frederick B; Wilkinson S; Hirashima F; Nassar L; Lyoo IK; Koch P; Jones S; Hwang J; Sung Y; Villafuerte RA; Maier G; Hsu R; Hashoian R; Renshaw PF
    J Clin Pharm Ther; 2006 Jun; 31(3):261-73. PubMed ID: 16789992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.
    Malet-Martino M; Gilard V; Desmoulin F; Martino R
    Clin Chim Acta; 2006 Apr; 366(1-2):61-73. PubMed ID: 16337167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous 3D NMR spectroscopy of proton-decoupled fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy.
    Gonen O; Murphy-Boesch J; Li CW; Padavic-Shaller K; Negendank WG; Brown TR
    Magn Reson Med; 1997 Feb; 37(2):164-9. PubMed ID: 9001138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous 3D NMR spectroscopy of fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy.
    Li CW; Gonen O
    Magn Reson Med; 1996 Jun; 35(6):841-7. PubMed ID: 8744011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.
    Schlemmer HP; Becker M; Bachert P; Dietz A; Rudat V; Vanselow B; Wollensack P; Zuna I; Knopp MV; Weidauer H; Wannenmacher M; van Kaick G
    Cancer Res; 1999 May; 59(10):2363-9. PubMed ID: 10344745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study for clinical pharmacokinetics of oral fluorine anticancer medicines using the commercial MRI system 19F-MRS.
    Ikehira H; Girard F; Obata T; Ito H; Yoshitomi H; Miyazaki M; Nakajima N; Kamei H; Kanazawa Y; Takano H; Ito H; Tanada S; Sasaki Y
    Br J Radiol; 1999 Jun; 72(858):584-9. PubMed ID: 10560341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver.
    Murphy-Boesch J; Li CW; He L; Padavic-Shaller KA; Negendank W; Brown TR
    Magn Reson Med; 1997 Mar; 37(3):321-6. PubMed ID: 9055218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
    Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
    Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.